Mia Weiss, M.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mia Weiss, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06968988 · Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue SarcomaWashington University School of Medicine · suspended · Metastatic Soft-tissue Sarcoma · principal investigator
- Ph1NCT05813327 · Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaWashington University School of Medicine · terminated · Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue · principal investigator
- Ph2NCT04551430 · Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue SarcomaWashington University School of Medicine · active not recruiting · Metastatic Soft-tissue Sarcoma · principal investigator
- Ph1NCT04337177 · Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsValent Technologies, LLC · active not recruiting · Solid Tumors, Neuroblastoma, Rhabdomyosarcoma · principal investigator
- Ph2NCT03449901 · ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung CancerWashington University School of Medicine · completed · Soft Tissue Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- USING ARGININE METABOLIC THERAPIES FOR SARCOMAR01CA227115 · NCI · WASHINGTON UNIVERSITY · PI Brian Andrew Van Tine · fiscal years 2019 to 2023Named on NCT03449901
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.